Published: January 25th, 2022,
Last updated: January 25th, 2022
It is expected that on Thursday, the European Medicines Agency (EMA) will decide whether to approve Pfizer’s COVID drug Paxlovid. This was said by Peter Liese, a member of the EU Parliament, in an interview with journalists. He expects that after a positive EMA vote, the EU Commission will formally approve the drug on the same day or on Friday at the latest.